UNSPSC 41202034: Reagents for detection of specific novel influenza a viruses

In this classification, Reagents for detection of specific novel influenza a viruses are devices used in test to identify specific Reagents for detection of specific novel influenza a viruses antibodies in serum. US FDA regulates Reagents for detection of specific novel influenza a viruses under 21 CFR 866.3332 and under FDA product code NXD.

UNSPSC 41202034 Reagents for detection of specific novel influenza a viruses is a Commodity code that in practice covers rapid diagnostic and confirmatory testing supplies used in public health surveillance and clinical laboratory operations, including HIV and syphilis reagents, drug-testing supplies, and related consumables for specific analyzer platforms. State and local health departments, criminal justice agencies, county health services, and municipal public health programs are the primary issuing bodies, with the Illinois Department of Public Health, Collin County Texas, Gwinnett County Georgia, and the City of Austin appearing as repeat recent buyers. Work solicited includes Abbott ARCHITECT analyzer consumables (reagent kits, calibrators, control kits, probes, and maintenance services), rapid HIV test kits (Abbott Determine brand), drug-testing supplies compatible with drugs of abuse analyzers, and sexually transmitted infection testing reagents (gonorrhea/chlamydia and syphilis) in quantities ranging from under 400 units annually to 25,000+ tests per year. Contracts typically run one to five years with optional renewals, and estimated values range from approximately $38,000 for emergency sole-source buys to $900,000 over five years for high-volume state laboratory operations.

Recent activity concentrates in Illinois, Texas, and Georgia. The Illinois Department of Public Health issued an emergency procurement in May 2026 for Abbott HIV/Syphilis reagents totaling $38,079.50 and a change order in September 2026 (due October 13, 2026) increasing gonorrhea/chlamydia testing volumes from 15,000 to 25,000 annual tests and contract cost from $525,000 to $900,000 over five years under an existing IFB. The City of Austin issued two consecutive IFBs for rapid HIV test kits (initial posting June 15, 2026, due July 17; rebid posted August 10, 2026, due September 3) specifying Abbott Determine kits at approximately 375 test units and 79 control units annually. Collin County issued an RFP in September 2026 (due July 23) for offender specimen collection and drug testing services covering approximately 25,031 annual tests with an estimated value of $600,000 over two years plus three optional one-year renewals, and an earlier IFB in August 2026 (due October 2, 2025) for general laboratory services with approximately $70,000 estimated annual value. Gwinnett County posted an RFP in September 2026 (due October 14) for drug-testing supplies compatible with an existing analyzer, though limited scope detail was available in the source.